Abnormal Biliary Lipid Composition in Cystic Fibrosis

Authors:
  • CRClaude C. Roy
    Claude C. Roy
  • AWAndrée M. Weber
    Andrée M. Weber
  • CMClaude L. Morin
    Claude L. Morin
  • JCJean-Claude Combes
    Jean-Claude Combes
  • DNDaniel Nusslé
    Daniel Nusslé
  • AMAlbert Mégevand
    Albert Mégevand
  • RLRoger Lasalle
    Roger Lasalle
  • LCLiette Chartrand
    Liette Chartrand
  • GLGuy Lepage
    Guy Lepage
  • AFAndré Fontaine
    André Fontaine

Abstract
Because of the increased incidence of gallstones in cystic fibrosis we compared biliary lipid composition in 26 patients with cystic fibrosis, seven children with cholelithiasis but no cystic-fibrosis and 13 controls. Eighteen of the cystic fibrosis group had cholecystograms, and only one had gallstones. In 14 patients with cystic fibrosis who had stopped taking pancreatic enzymes for one week molar percentage of lipid composition accounted for by cholesterol (mean ± S.E., 16.3±2.9) and saturation index (2.0±0.3) were comparable to values of the cholelithiasis group and higher (P<0.01) than those of controls. In 12 patients with cystic fibrosis taking pancreatic enzymes, molar percentage of cholesterol (8.6±1.7) and saturation index (1.0±0.1) did not differ from those of controls; in cystic fibrosis there was a preponderance of cholic over chenodeoxycholic acid both off (1.7±0.2) and on (1.9±0.3) therapy as compared to the cholelithiasis (0.7±0.1) and control (0.8±0.0) groups. The glycine/taurine ratio of conjugated bile acids was lower in enzyme-treated patients with cystic fibrosis (3.7±0.6) than in patients off treatment (6.4±1.0), but was higher (P<0.01) than in controls (1.8±0.2). Bile is lithogenic in untreated cystic fibrosis and responds to pancreatic enzymes. (N Engl J Med 297:1301–1305, 1977)
Keywords

This publication has 31 references indexed in Scilit: